title: Use of short-course class 1 topical glucocorticoid under occlusion for the rapid control of erythrodermic psoriasis.
authors.affiliation: Harvard Medical School, Boston, Mass.
authors.forename: J L
authors.initials: JL
authors.lastname: Arbiser
authors.forename: K
authors.initials: K
authors.lastname: Grossman
authors.forename: E
authors.initials: E
authors.lastname: Kaye
authors.forename: K A
authors.initials: KA
authors.lastname: Arndt
mesh_terms: D000287:Administration, Topical; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D001623:Betamethasone / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D003873:Dermatitis, Exfoliative / Q000150:complications / Q000188:drug therapy*; D005260:Female; D005938:Glucocorticoids; D006801:Humans; D008297:Male; D008875:Middle Aged; D009779:Occlusive Dressings; D011565:Psoriasis / Q000150:complications / Q000188:drug therapy*; D013997:Time Factors
chemical_list: D000893:Anti-Inflammatory Agents; D005938:Glucocorticoids; C011175:betamethasone-17,21-dipropionate; D001623:Betamethasone